Overview of key factors in improving access to acute stroke care

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  El Khoury, Ramy ^a   Jung, Richard ^b   Nanda, Ashish ^c   Sila, Cathy ^e   Abraham, Michael G ^e   Castonguay, Alicia C ^e   Zaidat, Osama O ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c University of Missouri   (United States)

^d FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITAL ADMINISTRATOR; HOSPITAL CARE; HUMAN; MECHANICAL THROMBECTOMY; MEDICAL EDUCATION; MEDICOLEGAL ASPECT; MORTALITY; OUTCOME ASSESSMENT; PATIENT TRANSPORT; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; SOCIOECONOMICS; TELEMEDICINE; TERTIARY HEALTH CARE; BLOOD CLOT LYSIS; LAW; MEDLINE;

EID: 84867525164     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182695a2a     Document Type: Article

References (51)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Deng YZ, Reeves MJ, Jacobs BS, et al., Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology 2006;14:306-312.
3. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011;42:1952-1955.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
5. Ogawa A, Mori E, Minematsu K, et al., MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-2639.
6. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000;55:1649-1655.
7. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-1072.
8. Marx JJ, Gube C, Faldum A, et al. An educational multimedia campaign improves stroke knowledge and risk perception in different stroke risk groups. Eur J Neurol 2009;16:612-618.
9. Miyamatsu N, Kimura K, Okamura T, et al. Effects of public education by television on knowledge of early stroke symptoms among a Japanese population aged 40 to 74 years: a controlled study. Stroke 2012;43:545-549.
10. Acker JE 3rd, Pancioli AM, Crocco TJ, et al; American Heart Association; American Stroke Association Expert Panel on Emergency Medical Services Systems, Stroke Council. Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke 2007;38:3097-3115.
11. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999;33:373-378.
12. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000;31:71-76.
13. Buck BH, Starkman S, Eckstein M, et al. Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke 2009;40:2027-2030.
14. Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke 2005;36:1512-1518.
15. Demaerschalk BM, Bobrow BJ, Paulsen M. Phoenix Operation Stroke Executive Committee. Development of a metropolitan matrix of primary stroke centers: the Phoenix experience. Stroke 2008;39:1246-1253.
16. de la Ossa NP, Sánchez-Ojanguren J, Palomeras E, et al. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Neurology 2008;70:1238-1243.
17. Nedeltchev K, Arnold M, Brekenfeld C, et al. Pre-and in-hospital delays from stroke onset to intra-arterial thrombolysis. Stroke 2003;34:1230-1234.
18. Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 2011;42:1626-1630.
19. Albright KC, Branas CC, Meyer BC, et al. ACCESS: Acute Cerebrovascular Care in Emergency Stroke Systems. Arch Neurol 2010;67:1210-1218.
20. Chalela JA, Kasner SE, Jauch EC, Pancioli AM. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke 1999;30:2366-2368.
21. Olson MD, Rabinstein AA. Does helicopter emergency medical service transfer offer benefit to patients with stroke? Stroke 2012;43:878-880.
22. Leifer D, Bravata DM, Connors JJ 3rd, et al; American Heart Association Special Writing Group of the Stroke Council; Atherosclerotic Peripheral Vascular Disease Working Group; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association [erratum 2011;42:e369]. Stroke 2011;42:849-877.
23. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA 2000;283:3102-3109.
24. Lattimore SU, Chalela J, Davis L, et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS suburban hospital stroke center experience. Stroke 2003;34:e55-e57.
25. Rajamani K, Millis S, Watson S, et al. Thrombolysis for acute ischemic stroke in joint commission-certified and -noncertified hospitals in Michigan. J Stroke Cerebrovasc Dis Epub 2011 Aug. 16.
26. Prabhakaran S, McNulty M, O'Neill K, Ouyang B. Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke 2012;43:857-877.
27. Gropen TI, Gagliano PJ, Blake CA, et al. NYSDOH Stroke Center Designation Project Workgroup. Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology 2006;67:88-93.
28. Xian Y, Holloway RG, Chan PS, et al. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA 2011;305:373-380.
29. Lichtman JH, Jones SB, Wang Y, Watanabe E, Leifheit-Limson E, Goldstein LB. Outcomes after ischemic stroke for hospitals with and without joint commission-certified primary stroke centers. Neurology 2011;76:1976-1982.
30. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-1616.
31. Meretoja A, Roine RO, Kaste M, et al. Effectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from Finland. Stroke 2010;41:1102-1107.
32. McCartney LA, Fussner J, Richardson M, Sila C. A systems approach to stroke care: increased access to tissue plasminogen activator therapies. Stroke 2011;42:e153-e154.
33. Sila C, McCartney LA, Tinsley N, et al. A systems approach to stroke care: the University Hospitals Cleveland experience. Presented at the 62nd Annual American Academy of Neurology Meeting, April 2010; Toronto.
34. Truong VV, Sundararajan S, Pundik S, De Georgia M, Furlan AJ, Sila C. Safety of drip and ship IV tPA in acute stroke: the University Hospitals-Case Medical Center experience. Neurology 2009;72(suppl 3):A3.
35. Rymer MM, Thrutchley DE; Stroke Team at the Mid America Brain and Stroke Institute. Organizing regional networks to increase acute stroke intervention. Neurol Res 2005;27(suppl 1):S9-S16.
36. Rymer MM. Organization of regional referral network increases the acute stroke treatment rate. Presented at the International Stroke Conference/Annual American Stroke Association Meeting; February 16-18, 2006; Kissimmee, FL.
37. Audebert HJ, Kukla C, Clarmann von Claranau S, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the telemedic pilot project for integrative stroke care (TEMPiS) in Bavaria. Stroke 2005;36:287-291.
38. Meyer BC, Raman R, Hemmen T, et al. Efficacy of siteindependent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008;7:787-795.
39. Switzer JA, Hall CE, Close B, et al. A telestroke network enhances recruitment into acute stroke clinical trials. Stroke 2010;41:566-569.
40. Henninger N, Chowdhury N, Fisher M, Moonis M. Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke. Cerebrovasc Dis 2009;27(suppl 4):9-14.
41. Silva GS, Schwamm LH. Use of telemedicine and other strategies to increase the number of patients that may be treated with intravenous thrombolysis. Curr Neurol Neurosci Rep Epub 2011 Oct. 14.
42. Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2009;40:2616-2634.
43. Anderson ER, Smith B, Ido M, Frankel M. Remote assessment of stroke using the iPhone 4. J Stroke Cerebrovasc Dis Epub 2011 October 21.
44. Capampangan DJ, Wellik KE, Bobrow BJ, et al. Telemedicine versus telephone for remote emergency stroke consultations: a critically appraised topic. Neurologist 2009;15:163-166.
45. Pervez MA, Silva G, Masrur S, et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 2010;41:e18-e24.
46. Martin-Schild S, Morales MM, Khaja AM, et al. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe? J Emerg Med 2011;41:135-141.
47. Demaerschalk BM, Durocher DL. How diagnosis-related group 559 will change the US Medicare cost reimbursement ratio for stroke centers. Stroke 2007;38:1309-1312.
48. Demaerschalk BM, Hwang HM, Leung G. Cost analysis review of stroke centers, telestroke, and rt-PA. Am J Manag Care 2010;16:537-544.
49. Lattimore SU, Chalela J, Davis L, et al. NINDS Suburban Hospital Stroke Center. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke 2003;34:e55-e57.
50. Stroke Treatment and Ongoing Prevention Act (STOP Stroke Act), H. R. 898 and S. 1064, 109th Congress.
51. Gladstone DJ, Rodan LH, Sahlas DJ, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke 2009;40:3841-3844.